Dallas Clinical Research Unit: Sponsor overview

Describe ESMO in one word

Ovarian cancer: Research biomarkers

Fortrea FSP: Chart a Course for Success​

EPIC ERG Video: James Gunter interview on Work-Life Balance

Hope in a Dose | Ep 11 | CMC Foundations for FIH Success: Getting CGT-Ready from Day Zero

Cortex Conversations: Insights in Neuroscience | Ep 6 | Bridging the gap in rare neurological dis...

The Challenge of Site Readiness

Choosing the Right Sites

Multiphase CRU in Leeds UK

Fortrea Innovation & Technology Summit EU – 2 Nov, 2026

ASCEND APAC 2 year anniversary

The Adaptive Advantage: Transforming Clinical Development Through Flexible Trial Design-Alicia Baker

Radiopharmaceuticals Manufacturing & Distribution Constraints: When Precision Meets Pressure | Ep 3

Timing Is Everything: The Importance of Logistics in Radiopharmaceutical Trials | Ep 2

Why Radiopharmaceuticals? Scientific Promise + Market Momentum | Ep 1

Melinda Lane sits down with Oren Cohen, Chief Medical Officer

Madison Clinical Research Unit: Sponsor overview

Operation Trialblazer hot takes from Alicia Baker

From intern to impact - real journeys, real growth at Fortrea.

International Nurses Day

Global Oncology Trial Success: Collaboration & Agility

Fortrea Intelligent Technology: FIT - the future of clinical development

Advancing CAR-T Analysis for Pediatric B Cell Malignancies

Hope in a Dose | Ep 10 | Regulatory landscape for ATMPs in EU

Hope in a Dose | Ep 9 | CGT Development: External Control Arms

Hope in a Dose | Ep 8 | Inside China’s Cell & Gene Therapy Boom

Hope in a Dose | Ep 7 | Long-term Follow Up in Cell and Gene Therapy Trials

Hope in a Dose | Ep 6 | Tumor-Free Territory: Navigating CAR-T in Non-Oncology Landscapes

Hope in a Dose | Ep 5 | Early Phase Challenges in Advanced Therapies

Hope in a Dose | Ep 4 | Patients, Sites, and Speed: Building a Realistic CGT Trial Strategy and F...

Hope in a Dose | Ep 3 | Partners in Scale: CDMOs and CROs Working as One

Hope in a Dose | Ep 2 | CGT in Pediatric Patient Population

Hope in a Dose | Ep 1 | Breaking Ground: What Makes CGT Phase Trials Different

Ophthalmology Perspectives | Ep 3 | Gene Therapy, Patient-Centric Operations, and Risk-Benefit Ch...

Ophthalmology Perspectives | Ep 2 | Ophthalmology Trials at the Leeds CPU

Ophthalmology Perspectives | Ep 1 | Patient Recruitment in Ophthalmology Trials

Special Topics in Medicine | Ep. 2 | Rare Disease Day

Oncology trials demand precision

How a hybrid model accelerated global breast cancer trials

Rationale for targeting beyond reduction in energy intake

From FIH to POC - Designing Phase I/Ib Trials with Efficiency

Oncology trials demand precision. We deliver it.

Site CRO Relationships in Alzheimer's Research

Alzheimer’s Disease: Carole and Hank Stark share their emotional journey

Cell & Gene Therapy in Alzheimer's Disease Research

Special Topics in Medicine | Ep 1 | Redefining Precision Oncology: Imaging Innovations Driving Cl...

Digital Health Innovations in Alzheimer’s Disease Research

Patient-centric Alzheimer’s trials

Kevin Chan Interview - Take Four

Transforming Alzheimer’s Trials: Real Stories, Real Impact

Proactive planning to eliminate delays in clinical development

Interview Guide for Experienced Candidates v2

Internship Interview Guide

Tips to Create an Impressive CV

Pulse Check: The Cardiovascular Conversations | Ep. 2 | Coronary Imaging Innovation and the Path ...

Pulse Check: The Cardiovascular Conversations | Ep. 1 | Coronary Inflammation—The Next Frontier i...

Diabetes Dialogues | Ep. 3 | The human side of pediatric Type 1 diabetes

Diabetes Dialogues | Ep. 2 | The critical first 100 days for pediatric Type 1 diabetes patients

Diabetes Dialogues | Ep. 1 | Cracking the T1D cure code: From breakthrough science to breakthroug...